Literature DB >> 2213823

Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.

L J Street1, R Baker, T Book, C O Kneen, A M MacLeod, K J Merchant, G A Showell, J Saunders, R H Herbert, S B Freedman.   

Abstract

The synthesis and biochemical evaluation of novel 1,2,4-oxadiazole-based muscarinic agonists which can readily penetrate into the CNS is reported. Efficacy and binding of these compounds are markedly influenced by the structure and physicochemical properties of the cationic head group. In a series of azabicyclic ligands efficacy and affinity are influenced by the size of the surface area presented to the receptor, at the active site, and the degree of conformational flexibility. The exo-1-azanorbornane 16a represents the optimum arrangement, and this compound is one of the most efficacious and potent muscarinic agonists known. In a series of isoquinuclidine based muscarinic agonists efficacy and affinity are influenced by the geometry between the cationic head.group and hydrogen bond acceptor pharmacophore and steric bulk in the vicinity of the base. The anti configuration represented by 22a is optimal for muscarinic activity. Ligands with pKa below 6.5 show poor binding to the muscarinic receptor as exemplified by the diazabicyclic derivative 42.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2213823     DOI: 10.1021/jm00172a003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Synthesis of 2-(1,2,4-oxadiazol-3-yl)quinazolin-4(3H)-ones from diaminoglyoxime-based nitrones.

Authors:  Rahim Hosseinzadeh-Khanmiri; Abolghasem Moghimi; Ahmad Shaabani; Hassan Valizadeh; Seik Weng Ng
Journal:  Mol Divers       Date:  2015-04-22       Impact factor: 2.943

2.  Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor.

Authors:  Kevin W Gillman; John E Starrett; Michael F Parker; Kai Xie; Joanne J Bronson; Lawrence R Marcin; Kate E McElhone; Carl P Bergstrom; Robert A Mate; Richard Williams; Jere E Meredith; Catherine R Burton; Donna M Barten; Jeremy H Toyn; Susan B Roberts; Kimberley A Lentz; John G Houston; Robert Zaczek; Charles F Albright; Carl P Decicco; John E Macor; Richard E Olson
Journal:  ACS Med Chem Lett       Date:  2010-03-22       Impact factor: 4.345

3.  Synthesis and crystal structure of new heterocyles derived from saccharin and uracil carrying 1,2,4-oxadiazolylmethyl group.

Authors:  Yaşar Dürüst; Besra Özer; Benson M Kariuki; Benson M Cariuki
Journal:  Mol Divers       Date:  2015-03-10       Impact factor: 2.943

4.  Synthesis and crystal structure of new heterocycles containing 1,2,4-oxadiazole, 1,2,4-oxadiazolone (thione), hydantoin, and mercaptobenzimidazole units.

Authors:  Yaşar Dürüst; Özge Gözlükaya; Gülsün Özer; Frank R Fronczek
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

5.  Synthesis of phidianidines A and B.

Authors:  Hong-Yu Lin; Barry B Snider
Journal:  J Org Chem       Date:  2012-05-01       Impact factor: 4.354

Review 6.  Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Jack Bergman; Andrew Coop
Journal:  Biomedicines       Date:  2022-02-07

7.  Facile Synthesis of Tricyclic 1,2,4-Oxadiazolines-Fused Tetrahydro-Isoquinolines from Oxime Chlorides with 3,4-Dihydroisoquinoline Imines.

Authors:  Kaikai Wang; Yanli Li; Wei Zhang; Rongxiang Chen; Xueji Ma; Mingyue Wang; Nan Zhou
Journal:  Molecules       Date:  2022-05-10       Impact factor: 4.927

8.  Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.

Authors:  D J Triggle; Y W Kwon; P Abraham; M A Rahman; F I Carroll
Journal:  Pharm Res       Date:  1992-11       Impact factor: 4.200

9.  Novel Antimuscarinic Antidepressant-like Compounds with Reduced Effects on Cognition.

Authors:  Chad R Johnson; Brian D Kangas; Emily M Jutkiewicz; Gail Winger; Jack Bergman; Andrew Coop; James H Woods
Journal:  J Pharmacol Exp Ther       Date:  2021-03-12       Impact factor: 4.402

10.  3-(3-Methyl-phen-yl)-5-(quinolin-8-yl-meth-oxy)-1,2,4-oxa-diazole monohydrate.

Authors:  Lu Yang; Wei Liu; Han Wang; Xing-Wei Chen; Hai-Bo Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.